Package 68462-329-01

{"route": ["ORAL"], "spl_id": "770b4914-a475-4841-83f8-79261f115eff", "openfda": {"nui": ["N0000175562", "N0000000181"], "upc": ["0368462294017", "0368462329016"], "unii": ["V3888OEY5R", "1T0N3G9CRC"], "rxcui": ["897781", "897783", "897844", "897853"], "spl_set_id": ["39bad727-af4c-4d20-933b-7f287e88099a"], "pharm_class_epc": ["Angiotensin Converting Enzyme Inhibitor [EPC]"], "pharm_class_moa": ["Angiotensin-converting Enzyme Inhibitors [MoA]"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-329-01)", "package_ndc": "68462-329-01", "marketing_start_date": "20150225"}, {"sample": false, "description": "1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-329-10)", "package_ndc": "68462-329-10", "marketing_start_date": "20150225"}], "brand_name": "Trandolapril and Verapamil Hydrochloride", "product_id": "68462-329_770b4914-a475-4841-83f8-79261f115eff", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Angiotensin Converting Enzyme Inhibitor [EPC]", "Angiotensin-converting Enzyme Inhibitors [MoA]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "68462-329", "generic_name": "Trandolapril and Verapamil Hydrochloride", "labeler_name": "Glenmark Pharmaceuticals Inc., USA", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Trandolapril and Verapamil Hydrochloride", "active_ingredients": [{"name": "TRANDOLAPRIL", "strength": "4 mg/1"}, {"name": "VERAPAMIL HYDROCHLORIDE", "strength": "240 mg/1"}], "application_number": "ANDA079135", "marketing_category": "ANDA", "marketing_start_date": "20150225", "listing_expiration_date": "20271231"}